These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 37964878

  • 1. Development and validation of a diagnostic model for the identification of chronic ocular graft-versus-host disease (oGVHD).
    Shen Z, Hu B, Tao L, Ma J, Peng R, Zhao Y, Hong J.
    Front Med (Lausanne); 2023; 10():1277194. PubMed ID: 37964878
    [Abstract] [Full Text] [Related]

  • 2. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.
    Khan R, Nair S, Seth T, Mishra P, Mahapatra M, Agarwal T, Tandon R, Vanathi M.
    Indian J Med Res; 2015 Nov; 142(5):543-8. PubMed ID: 26658588
    [Abstract] [Full Text] [Related]

  • 3. Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.
    Vanathi M, Kashyap S, Khan R, Seth T, Mishra P, Mahapatra M, Tandon R.
    Eur J Ophthalmol; 2014 Nov; 24(5):655-66. PubMed ID: 24604604
    [Abstract] [Full Text] [Related]

  • 4. Biomarkers in Ocular Graft-Versus-Host Disease: Implications for the Involvement of B Cells.
    Shen Z, Ma J, Peng R, Hu B, Zhao Y, Liu S, Hong J.
    Transplant Cell Ther; 2022 Nov; 28(11):749.e1-749.e7. PubMed ID: 35914728
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ocular pain in ocular graft-versus-host disease patients with neurotrophic keratopathy.
    Wang S, Singh RB, Yuksel E, Musayeva A, Sinha S, Taketani Y, Dohlman TH, Dana R.
    Ocul Surf; 2022 Oct; 26():142-147. PubMed ID: 35948166
    [Abstract] [Full Text] [Related]

  • 9. Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Pietraszkiewicz AA, Payne D, Abraham M, Garced A, Devarasetty KC, Wall M, Menezes SM, Ugarte S, Pirsl F, Goklemez S, Ferris FL, Barrett J, Battiwalla M, Childs RW, Pavletic SZ, Bishop RJ.
    Bone Marrow Transplant; 2021 Aug; 56(8):1850-1858. PubMed ID: 33686249
    [Abstract] [Full Text] [Related]

  • 10. A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.
    Trindade M, Rodrigues M, Pozzebon ME, Aranha FJP, Colella MP, Fernandes A, Fornazari DO, de Almeida Borges D, Vigorito AC, Alves M.
    Sci Rep; 2022 Sep 23; 12(1):15926. PubMed ID: 36151252
    [Abstract] [Full Text] [Related]

  • 11. Tear inflammatory mediators and protein in eyes of post allogenic hematopoeitic stem cell transplant patients.
    Nair S, Vanathi M, Mahapatra M, Seth T, Kaur J, Velpandian T, Ravi A, Titiyal JS, Tandon R.
    Ocul Surf; 2018 Jul 23; 16(3):352-367. PubMed ID: 29723628
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of neurotrophic keratopathy in patients with chronic ocular graft-versus-host disease.
    Singh RB, Yuksel E, Sinha S, Wang S, Taketani Y, Luznik Z, Yin J, Dohlman TH, Dana R.
    Ocul Surf; 2022 Oct 23; 26():13-18. PubMed ID: 35843560
    [Abstract] [Full Text] [Related]

  • 13. Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Patients With Dry Eye Disease Associated With Ocular Graft-Versus-Host Disease.
    Wong CW, Le HL, Gombos DS, Yee RW.
    Cureus; 2024 Aug 23; 16(8):e66437. PubMed ID: 39246931
    [Abstract] [Full Text] [Related]

  • 14. Outcomes and complications of cataract surgery in patients with chronic ocular graft-versus-host-disease-a multicenter, retrospective analysis.
    Gehlsen U, Faust C, Blecha C, Dietrich-Ntoukas T, Eberwein P, Issleib S, Meyer-Ter-Vehn T, Braun R, Westekemper H, Steven P.
    Graefes Arch Clin Exp Ophthalmol; 2022 Aug 23; 260(8):2613-2622. PubMed ID: 35254513
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of Corneal Epithelial Changes and Related Factors in Ocular Chronic Graft-Versus-Host Disease (GVHD) by in Vivo Confocal Microscopy.
    Liu S, Peng R, Ma J, Shen Z, Hu B, Zhao Y, Hong J.
    Ocul Immunol Inflamm; 2024 May 23; 32(4):454-462. PubMed ID: 36758227
    [Abstract] [Full Text] [Related]

  • 17. Corneal biomechanical alterations in patients with chronic ocular Graft Versus-Host Disease.
    Giannaccare G, Pellegrini M, Taroni L, Bernabei F, Senni C, Grendele A, Scorcia V, Campos EC.
    PLoS One; 2019 May 23; 14(4):e0213117. PubMed ID: 31022204
    [Abstract] [Full Text] [Related]

  • 18. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.
    Rapoport Y, Freeman T, Koyama T, Engelhardt BG, Jagasia M, Savani BN, Tran U, Kassim AA.
    Cornea; 2017 Feb 23; 36(2):258-263. PubMed ID: 28060078
    [Abstract] [Full Text] [Related]

  • 19. Update on ocular graft-versus-host disease.
    Nair S, Vanathi M, Mukhija R, Tandon R, Jain S, Ogawa Y.
    Indian J Ophthalmol; 2021 May 23; 69(5):1038-1050. PubMed ID: 33913829
    [Abstract] [Full Text] [Related]

  • 20. Metagenomic Profiling of the Ocular Surface Microbiome in Patients After Allogeneic Hematopoietic Stem Cell Transplantation.
    Li J, Liang Q, Huang F, Liao Y, Zhao W, Yang J, Wen X, Li X, Chen T, Guo S, Liang J, Wei L, Liang L.
    Am J Ophthalmol; 2022 Oct 23; 242():144-155. PubMed ID: 35551905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.